This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Rallybio Ipa, LLC. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Oistein Ihle: Innovator in Antibody Development
Introduction
Oistein Ihle is a notable inventor based in Ski, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, his work focuses on innovative solutions for medical challenges.
Latest Patents
Ihle's latest patents include groundbreaking inventions related to antibodies against HPA-1a. The first patent provides an isolated antibody that specifically binds to HPA-1a. It also includes a nucleic acid molecule that encodes the antibody, along with compositions comprising the antibody. Furthermore, the patent outlines a method for producing the antibody and various methods and uses that employ it. Therapeutic applications of this antibody are also highlighted, particularly in the treatment or prophylaxis of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The second patent mirrors the first, reinforcing the importance of this antibody in medical treatments.
Career Highlights
Oistein Ihle is currently associated with Rallybio IPA, LLC, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to innovative solutions that address critical health issues.
Collaborations
Ihle collaborates with esteemed colleagues such as Bjorn Ragnar Skogen and Anne Husebekk. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Oistein Ihle's contributions to antibody development are significant and impactful. His patents not only showcase his innovative spirit but also hold promise for advancing medical treatments. The work he is doing at Rallybio IPA, LLC, alongside his colleagues, is paving the way for future breakthroughs in biotechnology.